Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ObvioHealth

Explore full profile

Global digital health organization providing real-world digital clinical trials that deliver better data

New York City, United StatesFounded 2017Biotech & Life Sciences
Valuation $100–250M Last recorded · 2023
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ObvioHealth and the history behind them.

About ObvioHealth

ObvioHealth is a digital health organization specializing in conducting virtual clinical trials. The company operates in the healthcare and pharmaceutical sectors, serving clients such as pharmaceutical companies, healthcare providers, and research institutions. ObvioHealth's proprietary platform and mobile application enable participants to engage in clinical studies from the comfort of their homes, ensuring safety and convenience. This approach allows for the collection of comprehensive and accurate data sets that reflect real-world behaviors. The business model is based on providing end-to-end solutions for clinical trials, from participant recruitment to data analysis, thereby generating revenue through service contracts and strategic partnerships. ObvioHealth's innovative approach not only enhances participant compliance but also accelerates the research process, making it more efficient and cost-effective. The company is committed to improving health outcomes by delivering high-quality, real-world evidence that substantiates product claims and informs strategic decisions.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
New York City, United States
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Tikehau Capital
  • SPRIM Ventures

Series A4 investors entered at this stage

  • TKS1
  • IQVIA
  • SPRIM Global Investments
  • Ayala

Series B and later3 investors entered at this stage

  • Dedalus Group
  • AT Capital
  • Novotech
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇸🇬 Singapore51.1%
🇺🇸 United States34%
🇦🇺 Australia6.4%
🇬🇧 United Kingdom4.3%
🇮🇳 India4.3%
5 countries shown
Web traffic by country
3.7K monthly visits
across markets
🇺🇸 United States75.7%
🇮🇳 India24.3%
Top 2 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ObvioHealth on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ObvioHealth on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.